CCL2 Blockade Augments Cancer Immunotherapy

Cancer Research - United States
doi 10.1158/0008-5472.can-09-2326
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Blockade of Immune Checkpoints in Cancer Immunotherapy

Nature Reviews Cancer
Cancer ResearchOncology
2012English

Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

Adjuvant Immunotherapy for Cancer: Both Dendritic Cell-Priming and Check-Point Inhibitor Blockade Are Required for Immunotherapy

Proceedings of the Japan Academy Series B: Physical and Biological Sciences
MultidisciplinaryBiological SciencesMedicineAgriculturalAstronomyPhysics
2018English

TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell Mediated Regression of Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

1-Adrenergic Blockade Augments Pulsatile PTH Secretion in Humans

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2003English

PAK4 Inhibition Improves PD-1 Blockade Immunotherapy

Nature Cancer
2019English

CCL2 at the Crossroad of Cancer Metastasis

JAK-STAT
2013English

Neural Blockade During Exercise Augments Central Command's Contribution to Carotid Baroreflex Resetting

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Gastric Cancer Immunotherapy

Russian Journal of Biotherapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy